Senseonics Holdings (SENS) Cash from Investing Activities (2015 - 2026)
Senseonics Holdings (SENS) posted quarterly Cash from Investing Activities of $18.0 million for Q1 2026, up 171.06% year-over-year from $6.6 million in Q1 2025, and down 20.52% quarter-over-quarter from $22.6 million in Q4 2025.
Senseonics Holdings (SENS) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Cash from Investing Activities for 12 consecutive years, with $18.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 171.06% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at -$10.1 million (up 43.46% YoY), while the FY2025 annual figure was -$53.4 million, down 262.68% from the prior year.
- Cash from Investing Activities slipped to $18.0 million in Q1 2026 per SENS's latest filing, from $22.6 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $47.7 million in Q4 2024 and bottomed at -$69.6 million in Q2 2025.
- Historically, Cash from Investing Activities has averaged $6.7 million across 5 years, with a median of $18.9 million in 2025.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 178881.82% — and 2024, when it plunged 967.93%.
- Senseonics Holdings' Cash from Investing Activities stood at $7.4 million in 2022, then jumped by 392.45% to $36.2 million in 2023, then surged by 31.69% to $47.7 million in 2024, then sank by 52.5% to $22.6 million in 2025, then slipped by 20.52% to $18.0 million in 2026.
- Business Quant data shows SENS's Cash from Investing Activities at $18.0 million in Q1 2026, $22.6 million in Q4 2025, and $18.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Senseonics Holdings | 560.79 Mn | 320.18 Mn | 8.56 Mn | -63.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -63.38 Mn |
| Jun 30, 2026 | -63.38 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | 22.64 Mn |
| Dec 31, 2025 | 22.64 Mn |
| Sep 30, 2025 | 18.89 Mn |
| Sep 30, 2025 | 18.89 Mn |
| Jun 30, 2025 | -69.63 Mn |
| Jun 30, 2025 | -69.63 Mn |
| Mar 31, 2025 | -25.33 Mn |
| Mar 31, 2025 | -25.33 Mn |
| Dec 31, 2024 | 47.67 Mn |
| Dec 31, 2024 | 47.67 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | -43.53 Mn |
| Jun 30, 2024 | -43.53 Mn |
| Mar 31, 2024 | 25.38 Mn |
| Mar 31, 2024 | 25.38 Mn |